New pill shows promise for Hard-to-Treat blood cancers in japanese patients
NCT ID NCT03198650
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tests a drug called acalabrutinib in Japanese adults with advanced B-cell blood cancers (like leukemia and lymphoma). The goal is to see if it is safe and helps control the cancer. Participants take the drug daily, and researchers monitor side effects and how well the cancer responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PART1: ADVANCED B-CELL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Chiba, 260-8717, Japan
-
Research Site
Chūōku, 104-0045, Japan
-
Research Site
Fukuoka, 812-8582, Japan
-
Research Site
Isehara-shi, 259-1193, Japan
-
Research Site
Izumo-shi, 693-8501, Japan
-
Research Site
Matsuyama, 791-0280, Japan
-
Research Site
Nagoya, 460-0001, Japan
-
Research Site
Nagoya, 464-8681, Japan
-
Research Site
Niigata, 951-8520, Japan
-
Research Site
Okayama, 700-8558, Japan
-
Research Site
Sapporo, 060-8638, Japan
-
Research Site
Sendai, 980-8574, Japan
-
Research Site
Suita-shi, 565-0871, Japan